The clinical stage company, backed by venture capital, aims to improve patient care by shifting from traditional open surgical routines to minimally invasive spinal surgery. NLT SPINE develops and markets medical devices for the surgical treatment of back pain, including implants and instruments for lumbar interbody fusion procedures. The company's products are based on its NonLinear technology, which allows for small surgical incisions and enhanced safety, predictability, and outcomes. NLT SPINE has two approved products for lumbar interbody fusion currently under limited release, with six additional products set to be released in 2014-2015, targeting most of the yearly $7.6 billion opportunity for spinal implants. The company is headquartered in Israel, with offices in Boston, MA.